{"id":"W4313202305","doi":"10.51731/cjht.2022.531","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Drug; Adjuvant; Oncology; Internal medicine; Cancer; Pharmacology; Immunotherapy; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006164851,0.0003196208,0.0003389053,0.0006231522,0.0002870384,0.00096228,0.0004330011,0.0005005057,0.009359042],"category_scores_gemma":[0.0008687662,0.00007850172,0.0005150037,0.0004412353,0.0002858281,0.0004852069,0.0003975273,0.0006741279,0.00273559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001857611,"about_ca_system_score_gemma":0.002640505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0191469,"about_ca_topic_score_gemma":0.05594778,"domain_scores_codex":[0.9996585,0.00008212713,0.00003097857,0.00004617401,0.0001303378,0.00005192632],"domain_scores_gemma":[0.999707,0.00004929331,0.00005967678,0.00001086528,0.0001306469,0.00004246837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004410461,0.00005772965,0.0009300074,0.003218856,0.00009610571,0.00009457929,0.00003327208,0.0002003185,0.003489363,0.003061687,0.08583316,0.902544],"study_design_scores_gemma":[0.0001744899,0.0004677565,0.003121367,0.002110875,0.0001311071,0.0005614001,0.00004133895,0.0001581236,0.003651152,0.0006085073,0.9889577,0.00001626079],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01619225,0.7976988,0.002352364,0.01050764,0.003065445,0.0003525356,0.002808273,0.0003277724,0.1666949],"genre_scores_gemma":[0.2226574,0.6257207,0.008975299,0.01744083,0.001459501,0.0004211232,0.005313854,0.00009152391,0.1179197],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0191469,"threshold_uncertainty_score":0.03807086,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03071242189749569,"score_gpt":0.2907010161769475,"score_spread":0.2599885942794519,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}